Omeros Corporation
OMER
$3.12
Share price
-1.11%
Change (1 day)
-46.29%
Change (1 year)
Categories
Omeros Corporation (OMER) - Net assets
Net assets on the balance sheet as of September 2023 : -$13.96 M
According to Omeros Corporation's latest financial reports the company has -$13.96 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Omeros Corporation - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $85.68 M | 260.32% |
| 2021-12-31 | $23.78 M | -119.69% |
| 2020-12-31 | $-0.13 B | 10.76% |
| 2019-12-31 | $-0.11 B | 8.85% |
| 2018-12-31 | $-0.11 B | 3459.2% |
| 2017-12-31 | $-2.82 M | -92.49% |
| 2016-12-31 | $-37.45 M | 42.74% |
| 2015-12-31 | $-26.24 M | -38.5% |
| 2014-12-31 | $-42.66 M | 132.02% |
| 2013-12-31 | $-18.39 M | 181.49% |
| 2012-12-31 | $-6.54 M | 17.59% |
| 2011-12-31 | $-5.56 M | -127.13% |
| 2010-12-31 | $20.47 M | -52.56% |
| 2009-12-31 | $43.14 M | -147.33% |
| 2008-12-31 | $-91.17 M | 30.35% |
| 2007-12-31 | $-69.95 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -493,032.91% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | -640,065.60% | 🇺🇸 USA |
 Genetic Technologies GENE | $3.28 M | -123.52% | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | $2.23 M | -116.00% | 🇺🇸 USA |